Search Results - "Demchenkova, E. Yu"

Comparative evaluation of recommendations for preclinical studies of transporter-mediated drug–drug interactions by Evteev, V. A., Bunyatyan, N. D., Demchenkova, E. Yu, Prokofiev, A. B.

“…Scientific relevance. Sound recommendations for preclinical studies of transporter- mediated pharmacokinetic interactions of medicinal products can help…”
Get full text

Clinical Pharmacology of Antimicrobials: Focus on the Safety of Vancomycin and Linezolid by Zhuravleva, M. V., Kuznetsova, E. V., Berdnikova, N. G., Prokofiev, A. B., Kameneva, T. R., Demchenkova, E. Yu

“…Scientific relevance. Vancomycin and linezolid are the antibacterial agents of choice for severe infections caused by multidrug-resistant pathogens, including…”
Get full text

Features of toxic nephropathy development during antibiotic therapy by Kazakov, R. E., Gorodetskaya, G. I., Archvadze, R. V., Zavtonev, A. V., Danilov, A. V., Fetlam, D. L., Ishalev, D. A., Berdnikova, N. G., Demchenkova, E. Yu

“…Scientist relevance. Antibacterials can have nephrotoxic effects because medicinal products of this class are primarily excreted by the kidneys. Aim. The study…”
Get full text

Aspects of the Safe Use of Antibacterial Drugs in Community-Acquired Pneumonia: the Implications of Drug-Drug Interactions by A. A. Taube, B. K. Romanov, E. V. Shubnikova, R. N. Alyautdin, M. V. Zhuravleva, O. A. Demidova, E. Yu. Demchenkova

“…Background. Drug-drug interactions can seriously affect the safety profile of a drug and are an important problem worldwide. Due to the aging of the…”
Get full text

Retrospective Analysis of the Safety of Antibacterial Medicinal Products for Elderly Patients with Community-Acquired Lower Respiratory Tract Infections by Gorodetskaya, G. I., Prokofiev, A. B., Serebrova, S. Yu, Demchenkova, E. Yu, Zhuravleva, M. V., Demidova, O. A., Alexandrova, T. V., Mazerkina, I. A., Sokova, E. A., Muslimova, O. V.

“…Cephalosporins are the empirical antibiotic therapy (ABT) of choice for patients with community-acquired pneumonia (CAP). When treated with antibiotics,…”
Get full text

Experimental Cell Line Models for Nephrotoxicity Screening by Mazerkina, I. A., Evteev, V. A., Prokofiev, A. B., Muslimova, O. V., Demchenkova, E. Yu

“…The aim of the study was to review literature data on cell models for experimental assessment of drug nephrotoxicity in vitro . Because of nephrotoxicity, 2%…”
Get full text

Evaluation of the Efficacy and Safety of Initial Empirical Antibiotic Therapy for Community-Acquired Pneumonia in Middle-Aged People by Alexandrova, T. V., Muslimova, O. V., Zhuravleva, M. V., Alexandrov, A. A., Gorodetskaya, G. I., Demchenkova, E. Yu, Demidova, O. A., Sokova, E. A., Mazerkina, I. A., Smirnova, Yu. А.

“…β-lactam antibiotics, including cephalosporins, are the drugs of choice for empirical antibiotic therapy (ABT) in patients with community-acquired pneumonia…”
Get full text

Experience of Using Therapeutic Drug Monitoring to Control the Safety of Vancomycin in Intensive Care Unit Patients with Sepsis by Prokofiev, A. B., Belkov, S. A., Kazakov, R. E., Berdnikova, N. G., Rodina, T. A., Melnikov, E. S., Danko, A. A., Voronova, N. E., Vafina, R. Z., Zavtoniev, A. V., Tsyganko, D. V., Demchenkova, E. Yu

“…Vancomycin is prescribed to patients in serious condition with infections caused by Gram-positive microorganisms; however, if the therapeutic plasma…”
Get full text

Pantoprazole niche among the GERD-medicines by Starodubtsev, A. K., Kurguzova, D. O., Demchenkova, E. Yu, Drozdov, V. N., Serebrova, S. Yu

“…Main groups of antisecretory drugs used in the treatment of acid-dependent diseases, including gastroesophageal reflux disease (GERD), are described in a…”
Get full text

β-Lactam Antibiotics—Drug-Drug Interaction Mediated by Organic Anion Transporters OAT1 and OAT3 by Mazerkina, I. A., Evteev, V. A., Prokofiev, A. B., Muslimova, O. V., Demchenkova, E. Yu

“…Organic anion transporters OAT1 and OAT3 play a key role in elimination of most β-lactam antibiotics. Since nonsteroidal anti-inflammatory drugs, antivirals,…”
Get full text

Inhibitors in the Management of Patients with Atherosclerotic Cardiovascular Diseases: Guidelines and Reimbursement Issues by Zhuravleva, M. V., Prokofiev, A. B., Shikh, E. V., Serebrova, S. Yu, Gorodetskaya, G. I., Demchenkova, E. Yu

“…Current guidelines for the management of patients with dyslipidemia define low-density lipoprotein cholesterol (LDL-C) as the primary target in addressing…”
Get full text

Major Aspects of Detection and Monitoring of Adverse Reactions Associated with Cephalosporin Antibiotic Treatment by Demchenkova, E. Yu, Gorodetskaya, G. I., Mazerkina, I. A., Zhuravleva, M. V., Kazakov, A. S., Gorodetskiy, M. V., Badriddinova, L. Yu, Serebrova, S. Yu

“…Widespread use of cephalosporin antibiotics in clinical practice calls for greater attention to the risk of adverse drug reactions. Information on serious or…”
Get full text

Topical Issues of Drug Safety, Possibilities of Improving of Pharmacovigilance by Zhuravleva, M. V., Romanov, B. K., Gorodetskaya, G. I., Muslimova, O. V., Krysanova, V. S., Demchenkova, E. Yu

“…Since 2010, Russia has been developing new drug legislation, internal quality control and safety of medical organizations, and has developed algorithms for…”
Get full text

PHARMACOGENETICS OF ORGANIC CATION TRANSPORTERS by V. A. Evteev, R. E. Kazakov, O. A. Muslimova, E. Yu. Demchenkova

“…This article describes basic information about the classification, structure, substrate specificity and expression of organic cation transporters. The…”
Get full text

Pharmacogenetic Approaches to Enhancing Efficacy and Safety of Statins as Illustrated by the Example of Atorvastatin by Kazakov, R. Ye, Checha, O. A., Mazerkina, I. A., Demchenkova, E. Yu, Aleksandrova, T. A., Evteev, V. A., Belkov, S. A., Prokofiev, A. B.

“…Statins are efficacious lipid-lowering drugs used for prevention of cardiovascular complications in patients with high blood cholesterol. The efficacy and…”
Get full text

The Mechanism of Action of Follistatin-like Protein-1 (FSTL-1) by Kukes, V. G., Olefir, Yu. V., Romanov, B. K., Prokofiev, A. B., Parfenova, E. V., Boldyreva, M. A., Goroshko, O. A., Parfenova, O. K., Gazdanova, A. A., Demchenkova, E. Yu

“…The paper provides current data on some proteins of the TGF- p family which are potentially capable of exerting a protective effect in diseases of the heart,…”
Get full text

Compendium of pH-sensitive polymers in gastroenterology drugs: focus on enteric coatings by Serebrova, S. Yu, Evteev, V. A., Demchenkova, E. Yu, Prokofiev, A. B.

“…This compendium for gastroenterologists and hepatologists contains information about pH-sensitive polymers used in dosage forms for oral administration and…”
Get full text

Generic drugs of direct antiviral action for the treatment of hepatitis C: features of bioequivalence studies by Eremenko, N. N., Uvarova, N. E., Serebrova, S. Yu, Demchenkova, E. Yu, Shikh, E. V.

“…Introduction . In the last decade, approaches to the treatment of chronic viral hepatitis C (HCV) have undergone significant changes. The new WHO strategy aims…”
Get full text

Kinetics of Omeprazole Release from Enteric Dosage Forms of Different Manufacturers by Serebrova, S. Yu, Kurguzova, D. O., Krasnykh, L. M., Vasilenko, G. F., Demchenkova, E. Yu, Eremenko, N. N., Kareva, E. N., Prokofiev, A. B.

“…A comparative dissolution kinetics test (CDKT) related to proton-pump inhibitors (PPIs), particularly omeprazole, using dissolution media with pH 1.2 and 6.8…”
Get full text

Irritable bowel syndrome: modern ideas about pathology and the possibility of its correction by Serebrova, S. Yu, Kurguzova, D. O., Krasnykh, L. M., Vasilenko, G. F., Demchenkova, E. Yu, Eremenko, N. N., Kareva, E. N., Prokofiev, A. B.

“…Among the  defecating disorders  with  constipation or diarrhea,  there  is a  group  of major  intestinal disorders  defined  by the  Rome IV Diagnostic …”
Get full text